Publications by authors named "Arkadi A Chines"

Claim this Profile
E
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Paul D Miller, Jonathan D Adachi, Ben-Hur Albergaria, Angela M Cheung, Arkadi A Chines

J Bone Miner Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture.
Santiago Palacios, Stuart L Silverman, Tobie J de Villiers, Amy B Levine, Stefan Goemaere, Arkadi A Chines

Menopause· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis.
Thomas J Beck, Thomas Fuerst, Kenneth W Gaither, Santosh Sutradhar, Amy B Levine, Arkadi A Chines

Bone· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosis.
Akira Itabashi, Kousei Yoh, Arkadi A Chines, Takami Miki, Masahiko Takada

J Bone Miner Metab· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal women.
William E McKeand, Gayle P Orczyk, James C Ermer, Arkadi A Chines

Clin Pharmacol Drug Dev· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling.
Joann V Pinkerton, Andrew G Bushmakin, Jill Racketa, Joseph C Cappelleri, Arkadi A Chines

Menopause· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.
Joann V Pinkerton, Kaijie Pan, Lucy Abraham, Jill Racketa, Kelly A Ryan, Arkadi A Chines

Menopause· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
Joann V Pinkerton, Jennifer A Harvey, Robert Lindsay, Kaijie Pan, Arkadi A Chines

J Clin Endocrinol Metab· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
Joann V Pinkerton, Lucy Abraham, Andrew G Bushmakin, Joseph C Cappelleri, Jill Racketa, Arkadi A Chines

J Womens Health (Larchmt)· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogens.
John Christopher Gallagher, Harry Shi, Sebastian Mirkin, Arkadi A Chines

Menopause· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.
Santiago Palacios, Tobie J de Villiers, Fiorenzo De Cicco Nardone, Amy B Levine, Robert Williams, Arkadi A Chines

Maturitas· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.
JoAnn V Pinkerton, Jennifer A Harvey, Kaijie Pan, John R Thompson, Kelly A Ryan, Arkadi A Chines

Obstet Gynecol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens.
Jennifer A Harvey, JoAnn V Pinkerton, Edmund C Baracat, Harry Shi, Arkadi A Chines

Menopause· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
Barry S Komm, Arkadi A Chines

Maturitas· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis.
Barry S Komm, Arkadi A Chines

Ther Adv Musculoskelet Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosis.
Akira Itabashi, Kousei Yoh, Arkadi A Chines, Takami Miki, Masahiko Takada

J Bone Miner Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.
Claus Christiansen, Charles H Chesnut, Jonathan D Adachi, Jacques P Brown, César E Fernandes, Arkadi A Chines

BMC Musculoskelet Disord· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.
David F Archer, JoAnn V Pinkerton, Wulf H Utian, José C Menegoci, Tobie J de Villiers, Arkadi A Chines

Menopause· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.
JoAnn V Pinkerton, David F Archer, Wulf H Utian, José C Menegoci, Amy B Levine, Arkadi A Chines

Menopause· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bazedoxifene acetate: a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
Arkadi A Chines, Barry S Komm

Drugs Today (Barc)· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
Stuart L Silverman, Claus Christiansen, Harry K Genant, Slobodan Vukicevic, José R Zanchetta, Arkadi A Chines

J Bone Miner Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
Paul D Miller, Arkadi A Chines, Claus Christiansen, Hans C Hoeck, David L Kendler

J Bone Miner Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis